基于白醇的碳酸盐作为选择性布基胆酶抑制剂:设计,合成,计算研究和生物金属复合能力
Maja Sviben1, Ilijana Odak2, Danijela Barić3
1Department of Organic Chemistry, Faculty of Chemical Engineering and Technology, University of Zagreb, Trg Marka Marulića 19, HR-10 000 Zagreb, Croatia.
Molecules (Basel, Switzerland)
|January 25, 2025
概括
研究人员开发了针对神经系统疾病的新型碳酸盐化合物,这些化合物向布基胆化酶 (BChE). 化合物1和7具有很高的选择性和强度,性能优于现有治疗方法.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 计算化学计算化学
背景情况:
- 胆酶抑制剂对于治疗神经系统疾病至关重要.
- Resveratrol类似物已经显示出作为胆酶抑制剂的前景.
- 开发选择性丁胆酶 (BChE) 抑制剂是一个关键的治疗目标.
研究的目的:
- 设计和合成基于stilbene骨架的新型碳酸盐化合物.
- 评估这些化合物对乙胆酶 (AChE) 和BCHE的抑制活性和选择性.
- 研究潜在候选药物的分子相互作用和ADMET特性.
主要方法:
- 新型碳酸盐化合物的合成 (1-13).
- 在体外酶抑制测定对ACHE和BCHE.
- 分子对接和分子动力学 (MD) 模拟.
- 对金属离子复合的光谱分析.
主要成果:
- 化合物1和7表现出BChE的强大和选择性抑制 (IC50值分别为0.12±0.09μM和0.38±0.01μM).
- 化合物1和7的抑制活性超过了对BChE的胺.
- 分子对接和MD模拟显示了有利的相互作用和复杂的稳定性.
- 基于白醇的碳酸盐显示出Fe3+离子复合的潜力.
结论:
- 新型碳酸盐1和7是高度选择性的BCHE抑制剂.
- 这些化合物具有有利的ADMET特性,并显示出治疗神经系统疾病的潜力.
- 这项研究强调了基于stilbene的碳酸盐在神经退行性疾病中的治疗潜力.
相关概念视频
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.5K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
515
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
515
Anticholinesterase Agents: Poisoning and Treatment
779
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
779
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
850
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
850
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
613
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
613
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.0K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.0K


